Recro Pharma's intravenous painkiller succeeds in trial, shares soar

July 26 (Reuters) - Recro Pharma Inc said an

intravenous version of its lead painkiller was successful in the

first of two pivotal late-stage trials, sending the company's

shares surging 50 percent...

Read more